[1] European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure[J]. J Hepatol, 2017, 66 (5) :1047-1081.
|
[2] FLAMM SL, YANG YX, SINGH S, et al. American Gastroenterological Association Institute guidelines for the diagnosis and management of acute liver failure[J]. Gastroenterology, 2017, 152 (3) :644-647.
|
[3] LEE WM, STRAVITZ RT, LARSON AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011[J]. Hepatology, 2012, 55 (3) :965-967.
|
[4] Organization Committee of 13th Asia-Pacific Congress of Clinical Microbiology and Infection. 13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure[J]. Hepatobiliary Pancreat Dis Int, 2013, 12 (4) :346-354.
|
[5] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2018) [J]. J Clin Hepatol, 2019, 35 (1) :38-44. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2018年版) [J].临床肝胆病杂志, 2019, 35 (1) :38-44.
|
[6] SUN YL, ZHAO JM, ZHOU GD, et al. Cut-off period of subclassification and pathological features of severe hepatitis based on clinical and pathological analyses[J]. Chin J Exp Clin Virol, 2003, 17 (3) :270-273. (in Chinese) 孙艳玲, 赵景民, 周光德, 等.重型肝炎发病时相及临床病理特征的研究[J].中华实验和临床病毒学杂志, 2003, 17 (3) :270-273.
|
[7] FYFE B, ZALDANA F, LIU C. The pathology of acute liver failure[J]. Clin Liver Dis, 2018, 22 (2) :257-268.
|
[8] ROVEGNO M, VERA M, RUIZ A, et al. Current concepts in acute liver failure[J]. Ann Hepatol, 2019, 18 (4) :543-552.
|
[9] NAYAK NC, DUTTA GUPTA S, TANDON A, et al. Pathology of subacute hepatic failure[J]. Indian J Gastroenterol, 1993, 12 (Suppl 3) :11-14.
|
[10] SARIN SK, CHOUDHURY A. Management of acute-onchronic liver failure:An algorithmic approach[J]. Hepatol Int, 2018, 12 (5) :402-416.
|
[11] SARIN SK, CHOUDHURY A. Acute-on-chronic liver failure:terminology, mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2016, 13 (3) :131-149.
|
[12] JINDAL A, RASTOGI A, SARIN SK. Reviewing the diagnostic criteria for acute-on-chronic liver failure[J]. Expert Rev Gastroenterol Hepatol, 2016, 10 (12) :1385-1395.
|
[13] WANG X, SARIN SK, NING Q. Definition of ACLF and inclusion criteria for extra-hepatic organ failure[J]. Hepatol Int, 2015, 9 (3) :360-365.
|
[14] SARIN SK, CHOUDHURY A, SHARMA MK. et al. Acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific association for the study of the liver (APASL) :An update[J]. Hepatol Int, 2019, 13 (4) :353-390.
|
[15] RASTOGI A, KUMAR A, SAKHUJA P, et al. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF) [J]. Virchows Arch, 2011, 459 (2) :121-127.
|
[16] JALAN R, MOOKERJEE RP. Acute-on-chronic liver failure:An early liver biopsy is essential?[J]. Gut, 2010, 59 (11) :1455-1456.
|
[17] KATOONIZADEH A, LALEMAN W, VERSLYPE C, et al. Early features of acute-on-chronic alcoholic liver failure:A prospective cohort study[J]. Gut, 2010, 59 (11) :1561-1569.
|
[18] RASTOGI A, BIHARI C, MAIWALL R, et al. Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure[J]. Virchows Arch, 2012, 461 (4) :393-398.
|
[19] GOLDBERG DS, NEWCOMB C, GILROY R, et al. Increased distance to a liver transplant center is associated with higher mortality for patients with chronic liver failure[J]. Clin Gastroenterol Hepatol, 2017, 15 (6) :958-960.
|
[20] ROSI S, PIANO S, FRIGO AC, et al. New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients:Can we use an imputed value of serum creatinine?[J]. Liver Int, 2015, 35 (9) :2108-2114.
|
[21] Kidney Disease:Improving global outcomes (KDIGO) acute kidney injury working group. KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int Suppl, 2012, 2 (1) :1-138.
|
[22] RAMREZ M. Multiple organ dysfunction syndrome[J]. Curr Probl Pediatr Adolesc Health Care, 2013, 43 (10) :273-277.
|
[23] WASMUTH HE, KUNZ D, YAGMUR E, et al. Patients with acute on chronic liver failure display“sepsis-like”immune paralysis[J]. J Hepatol, 2005, 42 (2) :195-201.
|
[24] ROLANDO N, WADE J, DAVALOS M, et al. The systemic inflammatory response syndrome in acute liver failure[J]. Hepatology, 2000, 32 (Part 1) :734-739.
|
[25] WU Z, HAN M, CHEN T. Acute liver failure:Mechanisms of immune-mediated liver injury[J]. Liver Int, 2010, 30 (6) :782-794.
|
[26] PUENGEL T, TACKE F. Repair macrophages in acute liver failure[J]. Gut, 2018, 67 (2) :202-203.
|
[27] LOUIS H, LE MOINE O, PENY MO, et al. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury[J]. Gastroenterology, 1997, 112 (3) :935-942.
|
[28] ISAYAMA F, FROH M, YIN M, et al. TNF alpha-induced Ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse[J]. Hepatology, 2004, 39 (3) :721-731.
|
[29] YAN Z, TAN W, ZHAO W, et al. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population[J]. J Viral Hepat, 2009, 16 (11) :775-783.
|
[30] LEIFELD L, CHENG S, RAMAKERS J, et al. Imbalanced intrahe-patic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B[J]. Hepatology, 2002, 36 (Part 1) :1001-1008.
|
[31] ANTONIADES CG, BERRY PA, WENDON JA, et al. The importance of immune dysfunction in determining out-come in acute liver failure[J]. J Hepatol, 2008, 49 (5) :845-861.
|
[32] RYO K, KAMOGAWA Y, IKEDA I, et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure[J]. Am J Gastroenterol, 2000, 95 (8) :2047-2055.
|
[33] SUZUKI H, TOYODA M, HORIGUCHI N, et al. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice[J]. Liver Int, 2009, 29 (10) :1562-1568.
|
[34] KUHLA A, EIPEL C, ABSHAGEN K, et al. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced in-flammatory liver injury[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 296 (5) :g1069-g1076.
|
[35] GROSCURTH P, FILGUEIRA L. Killing mechanisms of cytotoxic T lymphocytes[J]. News Physiol Sci, 1998, 13:17-21.
|